Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 201410-53-9, Rambazole, R115866, R-115866, N-(4-(2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)benzo[d]thiazol-2-amine, Talarozole (r enantiomer)
Molecular Formula
C21H23N5S
Molecular Weight
377.5  g/mol
InChI Key
SNFYYXUGUBUECJ-UHFFFAOYSA-N
FDA UNII
XKD9N5CJ6W

Talarozole has been investigated for the treatment of Psoriasis and Cutaneous Inflammation.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl]-1,3-benzothiazol-2-amine
2.1.2 InChI
InChI=1S/C21H23N5S/c1-3-15(4-2)20(26-14-22-13-23-26)16-9-11-17(12-10-16)24-21-25-18-7-5-6-8-19(18)27-21/h5-15,20H,3-4H2,1-2H3,(H,24,25)
2.1.3 InChI Key
SNFYYXUGUBUECJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCC(CC)C(C1=CC=C(C=C1)NC2=NC3=CC=CC=C3S2)N4C=NC=N4
2.2 Other Identifiers
2.2.1 UNII
XKD9N5CJ6W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. N-(4-(2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)-2-benzothiazolamine

2. R 115866

3. R-115866

4. R115866

5. Rambazole

2.3.2 Depositor-Supplied Synonyms

1. 201410-53-9

2. Rambazole

3. R115866

4. R-115866

5. N-(4-(2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)benzo[d]thiazol-2-amine

6. Talarozole (r Enantiomer)

7. Xkd9n5cj6w

8. 201410-66-4

9. N-[4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl]-1,3-benzothiazol-2-amine

10. Chembl459505

11. (+)-n-[4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine

12. 2-benzothiazolamine, N-[4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl]-

13. N-(4-((1rs)-2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)benzothiazol-2-amine

14. Rambazole (tn)

15. Talarozole [usan]

16. Talarozole (usan/inn)

17. Talarozole [usan:inn]

18. Unii-xkd9n5cj6w

19. 2-benzothiazolamine, N-(4-(2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)-

20. N-{4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine

21. R 115866

22. N-(4-(2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)-2-benzothiazolamine

23. Talarozole [inn]

24. Talarozole [who-dd]

25. Schembl721201

26. Schembl21020998

27. Gtpl11381

28. Dtxsid70942185

29. Chebi:102167

30. Bcp21218

31. Bcp28256

32. Bia41053

33. Bdbm50253810

34. Akos005067289

35. Cs-1343

36. Db13083

37. Ncgc00378894-01

38. Ncgc00378894-02

39. Hy-14531

40. Ws-02133

41. D09385

42. D85497

43. A926099

44. Q15410180

45. Rambazole; R115866; R-115866; R 115866

46. Talarozole R Enantiomer;r115866;r 115866;r-115866

47. R115866;r-115866;r 115866

48. (+/-)-n-[4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazol-amine

49. (+/-)-n-[4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl]-2-benzothiazolamine

50. N-{4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothi Azol-2-amine

51. N-{4-[2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 377.5 g/mol
Molecular Formula C21H23N5S
XLogP36
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count7
Exact Mass377.16741693 g/mol
Monoisotopic Mass377.16741693 g/mol
Topological Polar Surface Area83.9 Ų
Heavy Atom Count27
Formal Charge0
Complexity452
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Cytochrome P-450 Enzyme Inhibitors

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)


4.2 Mechanism of Action

Rambazole is a new generation all-trans retinoic acid metabolism blocking agent, highly specific against the retinoic acid 4-hydroxylase. The drug alleviates hyperproliferation and normalizes differentiation of the epidermis in animal models of psoriasis. All-trans-retinoic acid (RA) regulates epithelial differentiation and growth through activation of specific nuclear RA receptors (RARs). Rambazole acts by inhibiting the metabolic breakdown of the retinoid, increasing the biological efficacy of RA.